Tyra Biosciences Valuation
| TYRA Stock | USD 15.83 0.47 3.06% |
At this time, the company appears to be undervalued. Tyra Biosciences has a current Real Value of $19.4 per share. The regular price of the company is $15.83. Our model measures the value of Tyra Biosciences from inspecting the company fundamentals such as Shares Owned By Institutions of 98.92 %, shares outstanding of 50.6 M, and Return On Equity of -0.29 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tyra Biosciences' valuation include:
Price Book 2.2111 | Enterprise Value 447.2 M | Enterprise Value Ebitda (6.95) |
Undervalued
Today
Please note that Tyra Biosciences' price fluctuation is somewhat reliable at this time. Calculation of the real value of Tyra Biosciences is based on 3 months time horizon. Increasing Tyra Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tyra Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tyra Stock. However, Tyra Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.83 | Real 19.4 | Target 24.4 | Hype 16.13 | Naive 18.88 |
The real value of Tyra Stock, also known as its intrinsic value, is the underlying worth of Tyra Biosciences Company, which is reflected in its stock price. It is based on Tyra Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Tyra Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Tyra Biosciences helps investors to forecast how Tyra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tyra Biosciences more accurately as focusing exclusively on Tyra Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tyra Biosciences' intrinsic value based on its ongoing forecasts of Tyra Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tyra Biosciences' closest peers. If more than one evaluation category is relevant for Tyra Biosciences we suggest using both methods to arrive at a better estimate.
Tyra Biosciences Cash |
|
Tyra Valuation Trend
Comparing Tyra Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Tyra Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Tyra Biosciences Total Value Analysis
Tyra Biosciences is at this time projected to have valuation of 447.23 M with market capitalization of 801.05 M, debt of 6.5 M, and cash on hands of 275.11 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tyra Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
447.23 M | 801.05 M | 6.5 M | 275.11 M |
Tyra Biosciences Asset Utilization
One of the ways to look at asset utilization of Tyra is to check how much profit was generated for every dollar of assets it reports. Tyra Biosciences has a negative utilization of assets of -0.2 %, losing $0.002021 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Tyra Biosciences shows how discouraging it operates for each dollar spent on its assets.Tyra Biosciences Ownership Allocation
Tyra Biosciences shows a total of 50.6 Million outstanding shares. The majority of Tyra Biosciences outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tyra Biosciences to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tyra Biosciences. Please pay attention to any change in the institutional holdings of Tyra Biosciences as this could imply that something significant has changed or is about to change at the company. Also note that roughly one million eight hundred sixty-seven thousand two hundred fifty-one invesors are currently shorting Tyra Biosciences expressing very little confidence in its future performance.Tyra Biosciences Profitability Analysis
Net Loss for the year was (69.13 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tyra Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tyra Biosciences and how it compares across the competition.
About Tyra Biosciences Valuation
The stock valuation mechanism determines Tyra Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Tyra Biosciences. We calculate exposure to Tyra Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tyra Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -353 K | -335.4 K |
Tyra Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 42.7 M |
Tyra Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Tyra Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tyra we look at many different elements of the entity such as Tyra's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tyra Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tyra Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tyra Biosciences' worth.Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |